Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets

Molecular & Cellular Proteomics(2023)10.1016/j.mcpro.2023.100602Source: DataRank Database

Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets is a research paper published in Molecular & Cellular Proteomics (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

pxd

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 1.86)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (22)

Weigang Ge ORCID,Yi Zhu ORCID,Azin Sayad,Augustin Luna ORCID,Mengge Lyu

Live enrichment

PubMed:37343696 PMC:PMC10392136 OpenAlex:https://openalex.org/W4381250708

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: 3100A0-688 107679

National Institutes of Health

Grant: Z01-BC 006150

National Natural Science Foundation of China

Grant: 81972492

Natural Science Foundation of Zhejiang Province

Grant: LR19C050001

European Research Council

Grant: ERC-2008-AdG 233226

European Research Council

Grant: ERC-20140AdG 670821

European Research Council

Grant: 233226

European Research Council

Grant: 670821

Swiss National Science Foundation

Grant: 107679

Canada Research Chairs

European Research Council

Princess Margaret Hospital Foundation

National Cancer Institute

FWCI

1.86

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.mcponline.org/article/S1535947623001135/pdf

publisherhttp://www.mcponline.org/article/S1535947623001135/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535947623001135?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535947623001135?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mcpro.2023.100602

Fields of Study

RNA modifications and cancerCancer, Lipids, and MetabolismBioinformatics and Genomic Networks

MeSH Terms

HumansSignal TransductionDrug Resistance, NeoplasmProteomicsCell Line, TumorCell ProliferationProto-Oncogene Proteins c-aktTriple Negative Breast NeoplasmsErbB Receptors

Keywords

PI3K/AKT/mTOR pathwayProteomicsProteomeTriple-negative breast cancerComputational biologyCancer researchProtein kinase BBiologyBreast cancerCell growthBioinformaticsSignal transductionCancerCell biologyGeneticsGeneEverolimusMachine LearningLapatinibDnmt1Egfr InhibitorMtor InhibitorTop2aAkt InhibitorData-independent AcquisitionPressure Cycling TechnologyProteotypeDus2Drug Perturbation

Sustainable Development Goals

SDG 0: Good health and well-being

Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein Targets

FAIR Checklist

Authors (22)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)